2. 考研
  3. Obesity is an epidemic to some and an opportunity to others. More than two-thirds of Americans are overweight. Find a way to bat

Obesity is an epidemic to some and an opportunity to others. More than two-thirds of Americans are overweight. Find a way to bat

admin2018-01-31  53
问题    Obesity is an epidemic to some and an opportunity to others. More than two-thirds of Americans are overweight. Find a way to battle obesity, 【C1】______a huge profit might be made. On February 22nd,  2013 one pharmaceutical firm, Vivus, took a small【C2】______towards this goal. A committee advising America’ s Food and Drug Administration(FDA)recommended Vivus’ s diet drug, Qnexa.【C3】______, the pill’ s long-awaited final approval may not come until April. The announcement mostly served as a reminder of a struggle which【C4】______fat into gold.
   Medical-device and pharmaceutical companies are quite【C5】______treating the problems that come with obesity. However, they can’t help consumers【C6】______weight. Allergan, a device-maker, has tried to use its gastric bands to enter the obesity market. The band is fitted near the top of patients’ stomach, which helps them feel full【C7】______during the meal. Allergan has captured about 70% of the worldwide market for gastric bands, but sales are now【C8】______. The recession has sapped consumers’ desire for expensive surgery. Some patients have【C9】______bands removed because they slipped or proved【C10】______. In January David Pyott, Allergan’s chief executive, said he would cancel an effort to market the band for teenagers. He is now trying to convince insurers of the gastric band’ s【C11】______.
   Drug companies have had even more【C12】______than device-makers. It has been 13 years since the FDA approved a【C13】______diet pill. That drug, Roche’s Xenical, has【C14】______side-effects. The FDA rejected Vivus’s Qnexa in 2010 over【C15】______for the safety of pregnant women and the quickening of patients’ heart rates.
   However, Vivus’ s new data in 2013 apparently satisfied the FDA’ s advisory committee.
   But the agency may yet【C16】______the drug.【C17】______Qnexa is approved, it is unclear that patients will buy it. Qnexa【C18】______two medicines that are already on the market. Both medicines are generic, which means that doctors may【C19】______the existing drugs rather than Qnexa’s more expensive version. For now, it is more【C20】______to treat fat patients than to try to make them slim.
【C8】
选项 A、increasing
B、rising
C、constraining
D、shrinking
答案D
解析 本题考查动词辨析。由but可知，此句的前后两部分为转折关系，前一部分讲的是“Allergan公司在全球胃部束带市场占有率达70％”，则后一部分必然是消极、负面的信息，故排除increasing和rising。shrink在此处用作不及物动词，指“收缩，退缩，畏缩”，符合句意“但是如今销量却有所收缩”，故D．shrinking为正确答案。constraining“限制，约束”是及物动词，需接宾语，故排除。
转载请注明原文地址:https://kaotiyun.com/show/9WBZ777K
0

考研英语一

相关试题推荐
随机试题
最新回复(0)